Triana Biomedicines, Inc.
4 private offerings reported to the SEC on Form D since 2016, $178.6M sold in all. Pharma, MA.
- Form D offerings: 4
- Reported sold: $178.6M
- Newest: Dec 4, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Dec 4, 2025 | $120.1M | $120.1M | Triana Biomedicines, Inc.Pharma · MA | Not amended | 0001815337-25-000003 |
| Feb 11, 2022 | $42.6M | $85.1M | Triana Biomedicines, Inc.Pharma · MA | Apr 19, 2022 | 0001815337-22-000002 |
| Sep 17, 2021 | $10.0M | $10.0M | Santi Therapeutics, Inc.Pharma · MA | Not amended | 0001815337-21-000001 |
| Jul 6, 2020 | $6.0M | $14.0M | Santi Therapeutics, Inc.Pharma · MA | Not amended | 0001815337-20-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Lexington, Ma
- Incorporated in
- DE
- Former names
- Santi Therapeutics, Inc.
- All SEC filings
- CIK 1815337 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR